Reported 2 months ago
Retirees looking for stable investments should consider AbbVie, Bristol Myers Squibb, and Gilead Sciences, all of which offer attractive dividend yields. AbbVie boasts a robust dividend history and promising growth despite challenges with its flagship drug. Bristol Myers Squibb promises steady income with a solid portfolio of emerging products. Gilead Sciences is recognized for its strong position in the HIV market and increasing focus on oncology, making it a reliable choice for long-term stability.
Source: YAHOO